Beam Therapeutics (BEAM) Return on Sales (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Return on Sales data on file, last reported at 0.03% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.03%, up 12.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (up 6.0% YoY), and the FY2025 annual result was 0.01%, up 5.0% from the prior year.
• Return on Sales eased to 0.03% in Q1 2026 per BEAM's latest filing, from 0.02% in the prior quarter.
• Over five years, Return on Sales peaked at 0.02% in Q4 2025 and troughed at 0.15% in Q1 2025.
• A 5-year average of 0.06% and a median of 0.05% in 2022 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2024: Return on Sales soared 33390 bps in 2022, then dropped 9 bps in 2024.
• A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then jumped by 124 bps to 0.0% in 2023, then slumped by 766 bps to 0.03% in 2024, then jumped by 171 bps to 0.02% in 2025, then tumbled by 243 bps to 0.03% in 2026.
• Business Quant data shows BEAM's Return on Sales at 0.03% in Q1 2026, 0.02% in Q4 2025, and 0.12% in Q3 2025.